Nalaganje...

Rutin as A Novel c-Met Inhibitory Lead for The Control of Triple Negative Breast Malignancies

Triple negative breast cancer (TNBC) has high metastatic and mortality potential and lacks effective and selective therapeutic options. Aberrant dysregulation of the receptor tyrosine kinase c-Met promotes TNBC progression, motility and survival and therefore considered a valid therapeutic target. A...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Nutr Cancer
Main Authors: Elsayed, Heba E., Ebrahim, Hassan Y., Mohyeldin, Mohamed M., Siddique, Abu Bakar, Kamal, Amel M., Haggag, Eman G., El Sayed, Khalid A.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6193555/
https://ncbi.nlm.nih.gov/pubmed/29083228
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/01635581.2017.1367936
Oznake: Označite
Brez oznak, prvi označite!